M&A Deal Summary

Stingray Healthcare Acquires Oncogard

On November 21, 2022, Stingray Healthcare acquired healthcare services company Oncogard

Acquisition Highlights
  • This is Stingray Healthcare’s 2nd transaction in the Healthcare Services sector.
  • This is Stingray Healthcare’s 2nd transaction in France.

M&A Deal Summary

Date 2022-11-21
Target Oncogard
Sector Healthcare Services
Buyer(s) Stingray Healthcare
Deal Type Add-on Acquisition

Target

Oncogard

Nîmes, France
Oncogard provides high-quality treatments to over 1,100 patients per year in Nîmes and the surrounding area. In addition, Oncogard offers oncology consultations and chemotherapy treatments at its main site in Nîmes as well as a second site at the public hospital in Alès.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Stingray Healthcare

Lausanne, Switzerland

Category Company
Sector Healthcare Services
DESCRIPTION

Stingray Healthcare supports the fight against cancer by ensuring the long-term success of treatment centres across Europe. The company teams up with cancer care professionals in a distinctive partnership model to help secure and develop their established practices, providing financial resources and strategic expertise to deliver the highest quality of care to patients. Stingray Healthcare is based in Lausanne, Switzerland.


DEAL STATS #
Overall 2 of 2
Sector: Healthcare Services M&A 2 of 2
Type: Add-on Acquisition M&A Deals 2 of 2
Country: France M&A 2 of 2
Year: 2022 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-09-20 MedEuropa

Bucharest, Romania

MedEuropa is building and operating state-of-the-art radiotherapy clinics for cancer treatment in Romania, a significantly undersupplied market, by way of a greenfield approach. MedEuropa was founded in 2016 and is based in Bucharest, Romania.

Sell -